Skincare demos, latest products coming to Dubai Derma on Feb 27

Dubai: The 21st edition of the Dubai World Dermatology and Laser Conference and Exhibition (Dubai Derma 2022), the largest and leading event dedicated to the dermatology and aesthetics industry in the Middle East, North Africa and sub-Saharan Africa. Indian continent, will be held in person from February 27 to March 1 at the Dubai World Trade Centre.

Under the theme “Shaping the Future of Dermatology and Aesthetics”, the event will provide a platform for industry players and professionals from around the world to discuss scientific insights and explore business opportunities in the sector.

Bringing together more than 20,000 visitors from 104 participating countries, Dubai Derma 2022 will feature more than 1,200 international products from 300 companies. The event will see strong representation from the countries of Korea, France, China, Spain, Turkey, Italy and Poland.

Over 349 speakers from around the world will share their insights in 326 scientific sessions featuring over 79 workshops and 90 digital poster presentations by international students. The main topics that will be covered at the event include medical, therapeutic, pediatric, surgical and cosmetic dermatology.

Strong points

Clinical case presentations aimed at enhancing understanding of various new diagnostic procedures and approaches are among the highlights of the event.

Dubai Derma 2022 is taking place against the backdrop of Dubai’s emergence as a leading medical tourism destination, including in the dermatology and aesthetics sector. As the field has seen many new scientific breakthroughs in recent years, the global skin care market is growing exponentially. By 2025, the global skincare market is expected to be worth approximately $189 billion (approximately 694 billion dirhams).

Dermatology products are an important growth engine for the sector. Considered a “quality of life field”, the dermatology market is driven by consumers who want to feel better about their appearance and gain confidence in their personal and professional lives.

The largest organ in the human body, the skin is the first to be affected by conditions both inside and outside the body – both positive and negative. Although skincare products are mainly used by women, in recent years, the market for men’s products has grown tremendously.

The younger population has also driven the growth in the market value of the sector due to the increased demand for products and procedures to treat skin conditions such as acne, blackheads, scars and to acquire a tanned appearance. The vast evolution of skincare routines and products over the past few years and the vast health and beauty awareness campaigns conducted by healthcare institutions and cosmetic companies are also supporting the growth of the market.

World market values

The global market for dermatology drugs is currently worth around $40.5 billion, while the global market for dermatology devices is valued at over $12 billion and is expected to surpass $20 billion by 2025. dermatological lasers, valued at $3 billion, is also increasing every year.

The market for dermo-cosmetics and fillers amounts to 70 billion dollars. Exhibitors at Dubai Derma 2022 will showcase state-of-the-art equipment with live demonstrations and the latest dermatological products that can improve a person’s ‘quality of life’.

Dr Ibrahim Galadari, Professor of Dermatology and Chairman of the Dubai Derma Conference, said: “This year we are celebrating the 21st edition of Dubai Derma, which has become one of the biggest dermatology events in the world. We thank INDEX Conferences and Exhibitions for helping us grow this event to its current stature. Dubai Derma brings together experts from around the world to share the latest scientific findings and information and the most advanced technology.

“The event will cover a range of vital topics in dermatology, and we are particularly looking forward to the live demonstrations at the event which will provide hands-on training for professionals. The event has established strong ties with various educational institutes, clinics and companies around the world. Most doctors in Dubai attend Dubai Derma before receiving their certifications.

Dr. Abdul Salam Al Madani, Executive Chairman of Dubai Derma and Chairman of INDEX Holding, said, “We are excited about the new possibilities and opportunities that Dubai Derma 2022 will bring to light. The event will highlight the latest scientific information and innovations in the field of dermatology, skin care and lasers. It will also feature a wide range of clinical case presentations that will help professionals gain in-depth knowledge of various diagnostic procedures and methods.

Live event

Dr. Hassan Galadari, Head of Dubai Derma’s Scientific Committee, said: “Dubai Derma not only provides a platform to dive deep into dermatology, but also offers a live event for industry professionals to connect to each other and build relationships on a unique basis. to a base.

He added, “We have expert speakers from elite international institutions who wish to visit Dubai as it is one of the few cities in the world that provides a safe environment for such global events with its protocols and preventative measures. globally referenced. The UAE has gone above and beyond normal health and safety standards to remove fear from everyone at social gatherings and ensure their safety. »

Dubai Derma is organized annually by INDEX Conferences and Exhibitions, a member of INDEX Holding, in cooperation with the Pan Arab League of Dermatology, the Arab Academy of Dermatological Aesthetics (AADA) and the League of Dermatologists of the GCC and with the support of the Government of Dubai and Dubai Health Authority. The event is also supported by Cosmetic Dermatology Society of India, Indian Association of Dermatologists, Venereologists and Leprologists (IADVL), International Society of Dermatology, Italian Society of Dermatology (SIDeMaST), Pakistan Association of Dermatologists and the Sri Lanka College of Dermatologists, the statement added.

About Thomas Hereford

Check Also

Pierre Fabre and Lonza enter into a manufacturing agreement for the W0180 antibody

Lonza will provide clinical drug manufacturing for W0180, an oncology drug candidate discovered by Pierre …